Active pharmaceutical ingredient (API), is the term used to refer to the biologically active component of a drug product (e.g. tablet, capsule). Drug products are usually composed of several components. The aforementioned API is the primary ingredient. Other ingredients are commonly known as “excipients” and these substances are always required to be biologically safe, often making up a variable fraction of the drug product.
The procedure for optimizing and compositing this mixture of components used in the drug is known as “formulation”. For example, if the API is a solid and the drug is required to have a liquid dosage form, such as a cough syrup, then the excipients would be the liquids that are used to formulate the syrup. The design criteria for any small molecule API is usually a combination of several factors that goes beyond the intended therapeutic effect, and usually heavily encompasses both pharmacokinetic and pharmacodynamic considerations, so for this reason, API molecules have many chemical functional groups.
The API form that is used in a formulation is often the most thermodynamically stable crystalline form. As such, the phenomenon of hydrogen bonding in combination with there being many functional groups on the API usually results in the available crystalline form being a hydrate.
Because of this fact the hydration behavior of crystalline APIs is of particularly high importance within the pharmaceutical industry, and is vastly studied from every possible angle. The state of hydration has a direct effect on the physical properties of the API, which in turn has a large impact on the drug processability and how the drug will eventually perform in-vivo, i.e. stability, solubility, and bioavailability.
A supplementary technique has been recently developed to complement more conventional analysis (methods such as calorimetric studies, nuclear magnetic resonance and vibrational spectroscopy) to study the behavior of hydration in organic crystalline solids.
By performing single crystal X-ray diffraction experiments with the ultimate objective being interpretation of the non-Bragg diffraction features, further insight can be gained into the mechanical and structural details of the dehydration of the crystal. These scattering features are reproduced and studied using computer models and the results are able to show the mechanistic relationships between changes in the lattice structure as stages of the overall drying process.
This first-of-its-kind exercise is to combine the mechanism of dehydration and non-Bragg scattering features from a single API crystal and the results will further improve the knowledge, formulation and choice of API used in drug manufacture today. It has been anticipated that these same data interpretation techniques will be useful to other researchers and that a more user-friendly modeling software can be made available in the future.